News 29.09.2021 Researchers find proof of dementia in the blood The scientist Peter Nirmalraj is seeking to develop a simple blood test to help diagnose dementia. A pilot study carried out in conjunction with ...
News 17.09.2021 Anjarium Biosciences receives 55.5 million Swiss francs Anjarium Biosciences AG has concluded a series A funding round with 55.5 million Swiss francs. The biotech company plans to use the proceeds to f...
News 30.01.2018 NeoGenomics establishes its European headquarters in Switzerland The U.S.-based provider of oncology testing services has chosen the canton of Vaud to open its first branch abroad.
투자자안내서 08.06.2023 투자자 안내서 안내서는 164페이지 분량으로, 사업 소재지로서 스위스의 주요 장점을 소개하고 오늘날 투자 환경, 생산 비용, 세금, 기반 시설, 새로운 기술, 금융 및 법률적 정보를 제공합니다.
事業展開ハンドブック 08.06.2023 事業展開ハンドブック イノベーティブな経済・技術開発拠点としてのスイスに関する情報をご提供いたします。経済構造、起業、税制、革新的な先端技術、労働市場、労働許可、法律関連の情報など、スイスで事業を行うにあたり必要な情報が網羅されています。
News 27.01.2021 Cellvie raises 5 million US dollars The life sciences firm Cellvie has successfully closed a seed funding round. With gross proceeds of 5 million US dollars, the aim now is to furth...
Globales Netzwerk Unsere Standorte weltweit Gemeinsam mit dem Eidgenössischen Departement für auswärtige Angelegenheiten (EDA) unterhalten wir derzeit Vertretungen in mehr als 25 ...
News 07.10.2021 Telemedicine is on the rise in Austria Telemedicine has been a topic in Austria for quite some time now, but it has gained a lot of importance due to coronavirus and the accompanying d...
News 24.09.2021 Lonza builds new filling line in Stein Lonza is investing in the development and manufacture of medicinal products in Switzerland. The pharmaceutical supplier is constructing a new fil...
Industry Report 18.10.2021 Get ahead in the digital health sector in Singapore Singapore has formulated various roadmaps and strategies that have contributed to the development of the digital health sector. Learn more about ...
News 14.09.2021 Kinarus secures capital commitment of 57 million Swiss francs The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group GEM. This should...
News 27.01.2021 Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to treat any form of cancer imm...